Colleen Ruegger

About Colleen Ruegger

With over 25 years of unparalleled expertise in global pharmaceutical product development, Colleen is a proven leader in advancing innovative therapies across diverse therapeutic areas. Her career, primarily forged at Novartis, reflects a steadfast commitment to improving and extending lives, driven by collaboration with top-tier innovators and industry trailblazers. Currently serving as a Therapeutic Area Head, Colleen excels in shaping competitive strategies that span the full spectrum of drug development—from early discovery to commercialization. Her leadership has propelled the success of over 50 programs globally, earning her recognition as a trusted partner to senior management and stakeholders alike. Colleen’s tenure at Novartis underscores her ability to navigate complex organizational landscapes, bridge functional silos, and foster collaboration with internal teams and external partners, including CROs and CDMOs. Her results-driven approach is matched only by her passion for mentorship and building consensus, enabling her to lead large, multidisciplinary teams to achieve global regulatory approvals, maximize commercial value, and deliver transformative solutions that resonate with patients worldwide. Colleen’s career highlights include driving operational excellence, spearheading due diligence for strategic acquisitions, and advancing patient engagement initiatives—all while maintaining an unwavering focus on innovation and sustainability in the pharmaceutical industry.*Key Core Competencies: R&D Leadership and Management, New Technology Development, Drug Development, Due Diligence, Global Team Leadership, and Culture Building & Transformation.*Therapeutic Areas: Cardiovascular, Renal, Metabolism, Neuroscience, Oncology, Global Health & In-Market Brands

Experience

1. Executive Director, Technical R & d (Trd) Therapeutic Area Head

   Novartis

   Aug 2017 — Present · East Hanover, NJ, US

   Drive strategic growth and operational excellence for the Cardiovascular-Renal-Metabolism portfolio, overseeing over 50 programs from research through commercialization while managing a high-performing team of 20+ professionals. Steer the strategic direction of technical development activities for Novartis’ Cardio Renal Metabolic and Global Health portfolios, collaborating with TRD teams across diverse functions and geographies to ensure seamless execution and impactful outcomes. Led the In-Market Brands and Global Health therapeutic from 20••••23.

Education

• Rutgers University

  BS

• Rutgers, The State University of New Jersey-New Brunswick

  PhD